• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

艾塞那肽-4通过MKK3和Akt-1在梗死心脏中诱导心肌保护作用。

Exendin-4 induces myocardial protection through MKK3 and Akt-1 in infarcted hearts.

作者信息

Du Jianfeng, Zhang Ling, Wang Zhengke, Yano Naohiro, Zhao Yu Tina, Wei Lei, Dubielecka-Szczerba Patrycja, Liu Paul Y, Zhuang Shougang, Qin Gangjian, Zhao Ting C

机构信息

Department of Surgery, Roger Williams Medical Center, Boston University Medical School, Boston University, Providence, Rhode Island;

Department of Emergency Medicine, Alpert Medical School, Brown University, Providence, Rhode Island;

出版信息

Am J Physiol Cell Physiol. 2016 Feb 15;310(4):C270-83. doi: 10.1152/ajpcell.00194.2015. Epub 2016 Jan 6.

DOI:10.1152/ajpcell.00194.2015
PMID:26739490
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4864970/
Abstract

We have demonstrated that glucagon like peptide-1 (GLP-1) protects the heart against ischemic injury. However, the physiological mechanism by which GLP-1 receptor (GLP-1R) initiates cardioprotection remains to be determined. The objective of this study is to elucidate the functional roles of MAPK kinase 3 (MKK3) and Akt-1 in mediating exendin-4-elicited protection in the infarcted hearts. Adult mouse myocardial infarction (MI) was created by ligation of the left descending artery. Wild-type, MKK3(-/-), Akt-1(-/-), and Akt-1(-/-);MKK3(-/-) mice were divided into one of several groups: 1) sham: animals underwent thoracotomy without ligation; 2) MI: animals underwent MI and received a daily dose of intraperitoneal injection of vehicle (saline); 3) MI + exendin-4: infarcted mice received daily injections of exendin-4, a GLP-1R agonist (0.1 mg/kg, ip). Echocardiographic measurements indicate that exendin-4 treatment resulted in the preservation of ventricular function and increases in the survival rate, but these effects were diminished in MKK3(-/-), Akt-1(-/-), and Akt-1(-/-);MKK3(-/-) mice. Exendin-4 treatments suppressed cardiac hypotrophy and reduced scar size and cardiac interstitial fibrosis, respectively, but these beneficial effects were lost in genetic elimination of MKK3, Akt-1, or Akt-1(-/-);MKK3(-/-) mice. GLP-1R stimulation stimulated angiogenic responses, which were also mitigated by deletion of MKK3 and Akt-1. Exendin-4 treatment increased phosphorylation of MKK3, p38, and Akt-1 at Ser129 but decreased levels of active caspase-3 and cleaved poly (ADP-ribose) polymerase; these proteins were diminished in MKK3(-/-), Akt-1(-/-), and Akt-1(-/-);MKK3(-/-) mice. These results reveal that exendin-4 treatment improves cardiac function, attenuates cardiac remodeling, and promotes angiogenesis in the infarcted myocardium through MKK3 and Akt-1 pathway.

摘要

我们已经证明,胰高血糖素样肽-1(GLP-1)可保护心脏免受缺血性损伤。然而,GLP-1受体(GLP-1R)启动心脏保护作用的生理机制仍有待确定。本研究的目的是阐明丝裂原活化蛋白激酶激酶3(MKK3)和Akt-1在介导艾塞那肽-4对梗死心脏的保护作用中的功能作用。通过结扎左冠状动脉前降支建立成年小鼠心肌梗死(MI)模型。将野生型、MKK3基因敲除(-/-)、Akt-1基因敲除(-/-)以及Akt-1基因敲除(-/-);MKK3基因敲除(-/-)小鼠分为以下几组:1)假手术组:动物接受开胸手术但不结扎;2)MI组:动物接受MI手术并每日腹腔注射溶媒(生理盐水);3)MI + 艾塞那肽-4组:梗死小鼠每日注射艾塞那肽-4,一种GLP-1R激动剂(0.1 mg/kg,腹腔注射)。超声心动图测量结果表明,艾塞那肽-4治疗可保留心室功能并提高生存率,但在MKK3基因敲除(-/-)、Akt-1基因敲除(-/-)以及Akt-1基因敲除(-/-);MKK3基因敲除(-/-)小鼠中这些作用减弱。艾塞那肽-4治疗分别抑制了心脏肥大并减小了瘢痕大小和心脏间质纤维化,但在MKK3、Akt-1基因敲除或Akt-1基因敲除(-/-);MKK3基因敲除(-/-)小鼠中这些有益作用消失。GLP-1R刺激可激发血管生成反应,而MKK3和Akt-1基因缺失也减弱了这种反应。艾塞那肽-4治疗增加了MKK3、p38和Akt-1在Ser129位点的磷酸化,但降低了活性半胱天冬酶-3和裂解的聚(ADP-核糖)聚合酶的水平;这些蛋白在MKK3基因敲除(-/-)、Akt-1基因敲除(-/-)以及Akt-1基因敲除(-/-);MKK3基因敲除(-/-)小鼠中减少。这些结果表明,艾塞那肽-4治疗可通过MKK3和Akt-1途径改善梗死心肌的心脏功能、减轻心脏重塑并促进血管生成。

相似文献

1
Exendin-4 induces myocardial protection through MKK3 and Akt-1 in infarcted hearts.艾塞那肽-4通过MKK3和Akt-1在梗死心脏中诱导心肌保护作用。
Am J Physiol Cell Physiol. 2016 Feb 15;310(4):C270-83. doi: 10.1152/ajpcell.00194.2015. Epub 2016 Jan 6.
2
Stimulation of glucagon-like peptide-1 receptor through exendin-4 preserves myocardial performance and prevents cardiac remodeling in infarcted myocardium.通过艾塞那肽-4刺激胰高血糖素样肽-1受体可维持心肌功能,并防止梗死心肌发生心脏重塑。
Am J Physiol Endocrinol Metab. 2014 Oct 15;307(8):E630-43. doi: 10.1152/ajpendo.00109.2014. Epub 2014 Aug 12.
3
Qiliqiangxin improves cardiac function and attenuates cardiac remodeling in rats with experimental myocardial infarction.芪苈强心改善实验性心肌梗死大鼠的心功能并减轻心脏重塑。
Int J Clin Exp Pathol. 2015 Jun 1;8(6):6596-606. eCollection 2015.
4
Apelin-13 increases myocardial progenitor cells and improves repair postmyocardial infarction.Apelin-13 可增加心肌祖细胞数量,改善心肌梗死后的修复。
Am J Physiol Heart Circ Physiol. 2012 Sep 1;303(5):H605-18. doi: 10.1152/ajpheart.00366.2012. Epub 2012 Jun 29.
5
Metabolically-inactive glucagon-like peptide-1(9-36)amide confers selective protective actions against post-myocardial infarction remodelling.代谢失活的胰高血糖素样肽-1(9-36)酰胺对心肌梗死后重塑具有选择性保护作用。
Cardiovasc Diabetol. 2016 Apr 14;15:65. doi: 10.1186/s12933-016-0386-5.
6
Effect of disruption of Akt-1 of lin(-)c-kit(+) stem cells on myocardial performance in infarcted heart.阻断 Akt-1 对梗死心脏中 lin(-)c-kit(+)干细胞心功能的影响。
Cardiovasc Res. 2010 Sep 1;87(4):704-12. doi: 10.1093/cvr/cvq110. Epub 2010 Apr 21.
7
Novel fusion of GLP-1 with a domain antibody to serum albumin prolongs protection against myocardial ischemia/reperfusion injury in the rat.新型 GLP-1 与白蛋白域抗体融合可延长对大鼠心肌缺血/再灌注损伤的保护作用。
Cardiovasc Diabetol. 2013 Oct 14;12:148. doi: 10.1186/1475-2840-12-148.
8
Targeting the glucagon receptor improves cardiac function and enhances insulin sensitivity following a myocardial infarction.靶向胰高血糖素受体可改善心肌梗死后的心脏功能并增强胰岛素敏感性。
Cardiovasc Diabetol. 2019 Jan 9;18(1):1. doi: 10.1186/s12933-019-0806-4.
9
Glucagon-like peptide-1 (GLP-1) mediates cardioprotection by remote ischaemic conditioning.胰高血糖素样肽-1(GLP-1)通过远程缺血预处理介导心脏保护作用。
Cardiovasc Res. 2016 Dec;112(3):669-676. doi: 10.1093/cvr/cvw216. Epub 2016 Oct 4.
10
HDAC inhibition elicits myocardial protective effect through modulation of MKK3/Akt-1.组蛋白去乙酰化酶抑制通过调节 MKK3/Akt-1 发挥心肌保护作用。
PLoS One. 2013 Jun 10;8(6):e65474. doi: 10.1371/journal.pone.0065474. Print 2013.

引用本文的文献

1
The Beneficial Effects of GLP-1 Receptor Agonists Other than Their Anti-Diabetic and Anti-Obesity Properties.胰高血糖素样肽-1受体激动剂除抗糖尿病和抗肥胖特性之外的有益作用。
Medicina (Kaunas). 2024 Dec 26;61(1):17. doi: 10.3390/medicina61010017.
2
GLP-1 receptor agonists and myocardial metabolism in atrial fibrillation.胰高血糖素样肽-1受体激动剂与心房颤动中的心肌代谢
J Pharm Anal. 2024 May;14(5):100917. doi: 10.1016/j.jpha.2023.12.007. Epub 2023 Dec 9.
3
Peptides Are Cardioprotective Drugs of the Future: The Receptor and Signaling Mechanisms of the Cardioprotective Effect of Glucagon-like Peptide-1 Receptor Agonists.肽类是未来的心脏保护药物:胰高血糖素样肽-1 受体激动剂心脏保护作用的受体和信号转导机制。
Int J Mol Sci. 2024 Apr 30;25(9):4900. doi: 10.3390/ijms25094900.
4
The potential of glucagon-like peptide-1 receptor agonists in heart failure.胰高血糖素样肽-1受体激动剂在心力衰竭中的潜力。
Front Physiol. 2022 Sep 20;13:983961. doi: 10.3389/fphys.2022.983961. eCollection 2022.
5
Insights from the use of erythropoietin in experimental Chagas disease.从促红细胞生成素在实验性恰加斯病中的应用得到的启示。
Int J Parasitol Drugs Drug Resist. 2022 Aug;19:65-80. doi: 10.1016/j.ijpddr.2022.05.005. Epub 2022 Jun 17.
6
Exendin-4 as a Versatile Therapeutic Agent for the Amelioration of Diabetic Changes.艾塞那肽-4作为改善糖尿病病变的多功能治疗药物。
Adv Pharm Bull. 2022 Mar;12(2):237-247. doi: 10.34172/apb.2022.025. Epub 2021 Jan 31.
7
The microRNA-520a-3p inhibits invasion and metastasis by targeting NF-kappaB signaling pathway in non-small cell lung cancer.微小 RNA-520a-3p 通过靶向非小细胞肺癌中的 NF-κB 信号通路抑制侵袭和转移。
Clin Transl Oncol. 2022 Aug;24(8):1569-1579. doi: 10.1007/s12094-022-02797-9. Epub 2022 Mar 5.
8
Current challenges in the treatment of cardiac fibrosis: Recent insights into the sex-specific differences of glucose-lowering therapies on the diabetic heart: IUPHAR Review 33.当前心脏纤维化治疗的挑战:降糖治疗对糖尿病心脏的性别特异性差异的最新认识:国际药理学联合会评论 33。
Br J Pharmacol. 2023 Nov;180(22):2916-2933. doi: 10.1111/bph.15820. Epub 2022 Mar 10.
9
Anti-apoptotic Effect of MiR-223-3p Suppressing PIK3C2A in Cardiomyocytes from Myocardial Infarction Rat Through Regulating PI3K/Akt Signaling Pathway.miR-223-3p 通过调控 PI3K/Akt 信号通路抑制 PIK3C2A 对心肌梗死后大鼠心肌细胞的抗凋亡作用
Cardiovasc Toxicol. 2021 Aug;21(8):669-682. doi: 10.1007/s12012-021-09658-x. Epub 2021 May 17.
10
Pharmacological validation of targets regulating CD14 during macrophage differentiation.在巨噬细胞分化过程中调节 CD14 的靶点的药理学验证。
EBioMedicine. 2020 Nov;61:103039. doi: 10.1016/j.ebiom.2020.103039. Epub 2020 Oct 7.

本文引用的文献

1
Incretin-based therapies: can we achieve glycemic control and cardioprotection?基于肠促胰岛素的治疗:我们能否实现血糖控制和心脏保护?
J Endocrinol. 2014 Mar 7;221(1):T17-30. doi: 10.1530/JOE-13-0195. Print 2014 Apr.
2
Circulating dipeptidyl peptidase IV activity correlates with cardiac dysfunction in human and experimental heart failure.循环中二肽基肽酶 IV 活性与人类和实验性心力衰竭中的心脏功能障碍相关。
Circ Heart Fail. 2013 Sep 1;6(5):1029-38. doi: 10.1161/CIRCHEARTFAILURE.112.000057. Epub 2013 Jul 26.
3
Perivascular delivery of encapsulated mesenchymal stem cells improves postischemic angiogenesis via paracrine activation of VEGF-A.血管周隙递送包封间充质干细胞通过旁分泌激活 VEGF-A 促进缺血后血管生成。
Arterioscler Thromb Vasc Biol. 2013 Aug;33(8):1872-80. doi: 10.1161/ATVBAHA.113.301217. Epub 2013 Jun 13.
4
HDAC inhibition elicits myocardial protective effect through modulation of MKK3/Akt-1.组蛋白去乙酰化酶抑制通过调节 MKK3/Akt-1 发挥心肌保护作用。
PLoS One. 2013 Jun 10;8(6):e65474. doi: 10.1371/journal.pone.0065474. Print 2013.
5
GLP-1 promotes angiogenesis in human endothelial cells in a dose-dependent manner, through the Akt, Src and PKC pathways.GLP-1 以剂量依赖的方式通过 Akt、Src 和 PKC 途径促进人内皮细胞的血管生成。
Metabolism. 2013 Sep;62(9):1279-86. doi: 10.1016/j.metabol.2013.04.010. Epub 2013 May 14.
6
Encapsulated glucagon-like peptide-1-producing mesenchymal stem cells have a beneficial effect on failing pig hearts.包被的胰高血糖素样肽-1 产生间充质干细胞对衰竭猪心脏有有益作用。
Stem Cells Transl Med. 2012 Oct;1(10):759-69. doi: 10.5966/sctm.2012-0064. Epub 2012 Sep 27.
7
Dipeptidyl peptidase-4 modulates left ventricular dysfunction in chronic heart failure via angiogenesis-dependent and -independent actions.二肽基肽酶-4通过血管生成依赖和非依赖作用调节慢性心力衰竭中的左心室功能障碍。
Circulation. 2012 Oct 9;126(15):1838-51. doi: 10.1161/CIRCULATIONAHA.112.096479. Epub 2012 Oct 3.
8
Inhibition of histone deacetylase-induced myocardial repair is mediated by c-kit in infarcted hearts.组蛋白去乙酰化酶诱导的心肌修复受梗死心脏中 c-kit 的抑制。
J Biol Chem. 2012 Nov 16;287(47):39338-48. doi: 10.1074/jbc.M112.379115. Epub 2012 Sep 28.
9
Glucagon-like peptide-1 and its cardiovascular effects.胰高血糖素样肽-1 及其心血管作用。
Curr Atheroscler Rep. 2012 Oct;14(5):422-8. doi: 10.1007/s11883-012-0265-9.
10
GLP-1 and cardioprotection: from bench to bedside.GLP-1 与心脏保护:从基础到临床。
Cardiovasc Res. 2012 May 1;94(2):316-23. doi: 10.1093/cvr/cvs123. Epub 2012 Mar 14.